Consultation on Methyl Anthranilate and Its Associated End-use Products, Proposed Re‑evaluation Decision PRVD2018-06

Methyl anthranilate is a pesticide registered for use in Canada by growers and licensed applicators to repel birds from fruit and turf. Names of products containing methyl anthranilate include Avigon and Avian Migrate. Methyl anthranilate is a naturally occurring substance in a variety of plants and fruits.

Following a scheduled re-evaluation under the Re-evaluation Program, Health Canada’s Pest Management Regulatory Agency (PMRA) is consulting Canadians on the proposal to continue the registration of products containing methyl anthranilate for sale and use in Canada. When used as a bird repellent according to the proposed label directions, the potential risk to human health and the environment is not expected to be of concern. Updates to label directions are being proposed to meet the current labelling standards.

For more information on the proposed decision open the “Proposed Re-evaluation Decision”.

How to Get Involved

This consultation is open for comment from 27 February 2018 to 28 May 2018 (90 calendar days).

To comment on PRVD2018-06:

Step 1
Request the full consultation document to read the Science Evaluation that is the basis of this proposed regulatory decision.

Step 2 
Submit comments to the PMRA Publications Section.

All comments received will be considered. A final re-evaluation decision will consider additional scientific information provided during the public comment period.
Please refer to the document title (for example: PRVD2018-06,  Methyl Anthranilate and Its Associated End-use Products) when providing comments.

Reporting to Canadians

Health Canada will make the results of this consultation available on this website. Once the decision is finalized, the PMRA will post a Re-evaluation Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.

If you have any questions, contact the Pest Management Information Service.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.